Celldex Therapeutics (CLDX) Return on Equity [ROE] (2011 - 2026)
Celldex Therapeutics' Return on Equity [ROE] was -51.34% in Q2 2026, down 21.95 percentage points from -29.39% a year earlier but up 6.35 percentage points from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Celldex Therapeutics came in at -40.62%, down 13.77 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -1.21 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -26.84% in FY2024 (+10.60 pp), -37.45% in FY2023 (-7.32 pp), -30.13% in FY2022 (-7.70 pp) and -22.43% in FY2021 (+16.98 pp).
- Quarterly Return on Equity [ROE] has moved between -57.69% (Q1 2026) and -16.47% (Q4 2021) over five years.
- Compared with a year earlier, Return on Equity [ROE] has declined for six straight quarters, with an average year-over-year change of -7.55 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2024 (a gain of 28.27 percentage points); the worst was Q1 2026 (a drop of 33.02 percentage points).
- Per Business Quant data, CLDX's Return on Equity [ROE] in the three quarters before Q2 2026 was -57.69% (Q1 2026), -45.98% (Q4 2025) and -35.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Celldex Therapeutics | 2.54 Bn | 2.54 Bn | - | -51.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.34% |
| Mar 31, 2026 | -57.69% |
| Dec 31, 2025 | -45.98% |
| Sep 30, 2025 | -35.82% |
| Jun 30, 2025 | -29.39% |
| Mar 31, 2025 | -24.67% |
| Dec 31, 2024 | -20.60% |
| Sep 30, 2024 | -19.26% |
| Jun 30, 2024 | -18.18% |
| Mar 31, 2024 | -22.85% |
| Dec 31, 2023 | -41.85% |
| Sep 30, 2023 | -47.54% |
| Jun 30, 2023 | -38.99% |
| Mar 31, 2023 | -37.73% |
| Dec 31, 2022 | -33.45% |
| Sep 30, 2022 | -29.83% |
| Jun 30, 2022 | -26.11% |
| Mar 31, 2022 | -18.84% |
| Dec 31, 2021 | -16.47% |
| Sep 30, 2021 | -23.94% |
API Access
Celldex Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();